Market Research Reports and Industry Reports

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company offers its products to diagnostics, life sciences and applied chemical markets. It serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 11
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15
Venture Financing 16
Molecular Assemblies Raises USD2.3 Million in Seed Financing 16
Partnerships 17
Agilent Tech Extends its Agreement with University of Leuven - Center for Human Genetics and University Hospitals Leuven 17
Agilent Technologies Enters into Agreement with Transcriptic 18
Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 19
Protea Biosciences Enters into Agreement with Agilent Technologies 20
Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 21
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 22
Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 23
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 24
Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 25
Dako Enters Into Co-Development Agreement With Merck 26
Agilent Technologies Enters Into Research Agreement With University of Queensland 27
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 28
Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 29
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 30
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 31
Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 32
Agilent Enters Into Research Agreement With Chungnam National University 33
Agilent Technologies Enters Into Agreement With Applied Proteomics 34
Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 35
Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 36
Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 37
Dako Enters Into Co-Development Agreement With Amgen 38
Dako Enters Into Co-Development Agreement With Amgen 39
Dako Enters Into Co-Development Agreement With Bristol-Myers 40
Agilent Technologies And University of Technology Sydney Expand Their Joint Venture 41
Agilent Technologies Enters Into Co-Development Agreement With Chungnam National University 42
Agilent Technologies Enters Into Research And Development Agreement With National University Of Singapore 43
Dako Denmark Enters Into Co-Development Agreement With Epitomics 44
Agilent Technologies Enters Into Co-Marketing Agreement With Sage Science 45
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 46
Licensing Agreements 47
Dako Enters into Licensing Agreement with OriGene Technologies 47
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 48
Debt Offering 49
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 49
Acquisition 51
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 51
Agilent Technologies Acquires Cartagenia for USD68.34 Million 52
Agilent Technologies To Acquire ABC Instrumentacion Analitica 53
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 54
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 55
Agilent Technologies Completes Acquisition Of BioSystem Development 57
Agilent Technologies Acquires Halo Genomics 58
Agilent Technologies Acquires BIOCIUS Life Sciences 59
Agilent Technologies Inc - Key Competitors 60
Agilent Technologies Inc - Key Employees 61
Agilent Technologies Inc - Locations And Subsidiaries 63
Head Office 63
Other Locations & Subsidiaries 63
Recent Developments 64
Strategy And Business Planning 64
Aug 09, 2016: Agilent Technologies to Build New Facility in Colorado, Increasing Pharmaceutical Manufacturing Capacity 64
Financial Announcements 65
Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results 65
Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results 66
Corporate Communications 67
Jul 18, 2017: Hans E. Bishop to Join Agilents Board of Directors 67
Legal and Regulatory 68
May 19, 2016: Twist Bioscience Retains Leading Law Firm Quinn Emanuel to Combat Lawsuit Filed by Agilent Technologies 68
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies 69
Product News 70
Oct 10, 2016: Agilent Technologies showcases innovative laboratory solutions at analytica China 2016 70
Sep 13, 2016: Agilent Technologies Lowers the Cost of Multi-Element Analysis 71
Aug 30, 2016: Agilent Technologies Introduces Transformational Technology for Gas Chromatography 72
Jun 06, 2017: Agilent Technologies Introduces New GC/Q-TOF System Enabling Greater Exploration of Unknown Chemical Samples 73
Jun 06, 2016: Agilent Technologies Launches New Solutions for Pharma, Biopharma, Metabolomics and Environmental Researchers Across Mass Spec Portfolio 74
Jun 05, 2017: Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer 75
May 10, 2016: Agilent Technologies Introduces InfinityLab Liquid Chromatography Instruments, Columns and Supplies 76
Apr 18, 2016: Agilent Technologies Introduces First Commercial Software for Metabolic Flux Analysis 77
Mar 21, 2017: Agilent Technologies Enhances Exome Sequencing for Clinical Research 78
Mar 08, 2017: Agilent Technologies Launches New Research-Grade Triple Quadrupole LC/MS System 79
Mar 07, 2017: Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System 80
Other Significant Developments 81
Oct 17, 2017: Agilent Expands SureGuide Portfolio with CRISPR-based Products to Accelerate Disease Research 81
Oct 20, 2016: Agilent Technologies Launches SureGuide CRISPR Libraries for Functional Genomics 82
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 83
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 84
Appendix 85
Methodology 85
About GlobalData 85
Contact Us 85
Disclaimer 85

List Of Tables

List of Tables
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Agilent Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 11
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15
Molecular Assemblies Raises USD2.3 Million in Seed Financing 16
Agilent Tech Extends its Agreement with University of Leuven - Center for Human Genetics and University Hospitals Leuven 17
Agilent Technologies Enters into Agreement with Transcriptic 18
Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 19
Protea Biosciences Enters into Agreement with Agilent Technologies 20
Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 21
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 22
Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 23
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 24
Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 25
Dako Enters Into Co-Development Agreement With Merck 26
Agilent Technologies Enters Into Research Agreement With University of Queensland 27
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 28
Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 29
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 30
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 31
Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 32
Agilent Enters Into Research Agreement With Chungnam National University 33
Agilent Technologies Enters Into Agreement With Applied Proteomics 34
Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 35
Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 36
Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 37
Dako Enters Into Co-Development Agreement With Amgen 38
Dako Enters Into Co-Development Agreement With Amgen 39
Dako Enters Into Co-Development Agreement With Bristol-Myers 40
Agilent Technologies And University of Technology Sydney Expand Their Joint Venture 41
Agilent Technologies Enters Into Co-Development Agreement With Chungnam National University 42
Agilent Technologies Enters Into Research And Development Agreement With National University Of Singapore 43
Dako Denmark Enters Into Co-Development Agreement With Epitomics 44
Agilent Technologies Enters Into Co-Marketing Agreement With Sage Science 45
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 46
Dako Enters into Licensing Agreement with OriGene Technologies 47
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 48
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 49
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 51
Agilent Technologies Acquires Cartagenia for USD68.34 Million 52
Agilent Technologies To Acquire ABC Instrumentacion Analitica 53
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 54
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 55
Agilent Technologies Completes Acquisition Of BioSystem Development 57
Agilent Technologies Acquires Halo Genomics 58
Agilent Technologies Acquires BIOCIUS Life Sciences 59
Agilent Technologies Inc, Key Competitors 60
Agilent Technologies Inc, Key Employees 61
Agilent Technologies Inc, Subsidiaries 63

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and

USD 250View Report

Agilent Technologies Inc Strategic Analysis Review- Agilent Technologies Inc SWOT, Outlook, Operations and Financial Profile

Agilent Technologies Inc Company Profile provides strategic analysis of Agilent Technologies Inc Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Taiga Biotechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Taiga Biotechnologies Inc (Taiga Biotech) is a biopharmaceutical company that develops protein and cellular therapies. The company develops therapies for diseases including cancers and infectious diseases. Its pipeline products include

USD 250View Report

Ormat Technologies Inc (ORA) - Power - Deals and Alliances Profile

Ormat Technologies, Inc. (Ormat), is a vertically integrated company that focuses on the geothermal and recovered energy generation. The company designs, develops, builds, owns, and operates the geothermal and recovered

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :85
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube